Jump to Navigation

Infant Sleep Positioning Aids

Infant Sleep Positioning Aids

Infant sleep positioning aids, intended to keep babies in a desired position while they sleep, have been available to the public for years and have been marketed as a solution to a number of infancy-related ailments.

Following the deaths of two babies, the Federal Food and Drug Administration (FDA) and the U.S. Consumer Product Safety Commission (CPSC) issued a joint warning for parents and caregivers to immediately stop using infant sleep positioning aids because of a grave product liability issue.

Over the past 13 years, the deaths of at least 12 infants between the ages of one and four months have been reported. The babies died when they suffocated within the cushions of their sleep positioner or became trapped between their sleep positioning aid and the side of a crib or bassinet and then suffocated.

Sleep positioning aids are generally flat, thin mats with side bolsters intended to keep the infant in a desired sleep position. Some models offer a built-in wedge intended to elevate an infant’s head.

Manufacturers of sleep positioners often claim that their products may lessen colic and ease gastroesophageal reflux disease, in which stomach acid backs up into the esophagus. Some advertise that their devices prevent plagiocephaly or “flat head” syndrome, a deformation that occurs when a baby’s skull develops a flat spot or becomes asymmetrical due to positional pressure.

Some manufacturers even claim that their products may reduce the risk of Sudden Infant Death Syndrome (SIDS), the leading cause of death in infants under one year of age.

The FDA has never cleared an infant sleep positioner to prevent or reduce the risk of SIDS. The FDA and CPSC said they were unaware of any scientific studies showing that infant sleep positioning aids prevent SIDS.

Because of the hazards now known to be associated with infant sleep aids, the FDA is requiring all manufacturers of even previously FDA-cleared products to submit clinical data showing that their products’ benefits outweigh the risks. The FDA is also asking these manufacturers to stop producing, marketing or distributing their products until after all data has been reviewed and approved.

The federal agencies are warning parents and caregivers that the use of sleep positioning aids is dangerous and unnecessary. They recommend infants be placed flat on their backs, on a firm surface, without pillows, quilts, blankets or toys. Consumers are being advised to follow the ABC’s of safe infant sleep: “alone” on the “back” in a bare “crib.”

The American Academy of Pediatrics also recommends that infants be placed on their backs for sleep. The Academy supports the federal government’s position, calling on the public not to use sleep positioners to prevent SIDS or to promote sleep.

Many of the injured infants suffocated after rolling from their side onto their stomach. In addition to the reported deaths, CPSC has received dozens of reports of close calls: babies who were put to sleep on their sides or backs, only to be found later in dangerous positions within or beside their sleep aids.

If your infant has been seriously injured by a sleep positioning aid or to discuss other cases of catastrophic personal injury or defective products, please contact Koskoff, Koskoff and Bieder at 1-800-366-4421, or use our online contact form.

Case Results

KK&B Attorneys Win Largest Medical Malpractice Verdict in CT
A Norwalk couple was awarded $58.6 million Wednesday, a record for a single incident of medical malpractice in Connecticut, in a case involving an obstetrician accused of waiting too long to perform a cesarean section and a boy who has cerebral palsy... read more

Smokeless Tobacco Maker Settles Suit
The nation's largest smokeless tobacco company agreed to settle for $5 million a lawsuit brought by the family of a decades-long user who died of mouth cancer... read more

In the News Damages

Silent Witnesses, New Insights, 'Black box' recorders in cars provide evidence in PI lawsuits
Bill Bloss interviewed by the Connecticut Law Tribune, on Monday, May 14, 2012.

Joshua Koskoff has been named a fellow of the International Society of Barristers
On May 7th, 2012, Joshua Koskoff has been named by the Fairfield County Business Journal.

Koskoff, Koskoff & Bieder attorney Bill Bloss represents exonerated inmate in first claim under new CT statute

Koskoff, Koskoff & Bieder attorney Sean McElligott named to Freedom of Information Commission
Connecticut Speaker of the House Chris Donovan has appointed a Bridgeport attorney to the state’s Freedom of Information Commission.

Koskoff, Koskoff & Bieder attorney Bill Bloss interviewed on WICC about the Supreme Court decision on Bridgeport public education

Koskoff, Koskoff & Bieder ranked Tier One in the US News & World Report
U.S. News Media Group and Best Lawyers® has listed the Connecticut-based law firm of Koskoff, Koskoff & Bieder as “tier one” in its 2011-2012 “Best Law Firms” rankings.

Community Involvement

Firm Donates $100,000 to Hospital
Attorney Chris Bernard of Koskoff, Koskoff & Bieder said his firm has donated $100,000 to Connecticut Children's Medical Center in Hartford. The funds have covered the cost of specialized medical equipment... read more

Koskoff, Koskoff & Bieder Has Become One of Connecticut's Most Successful Law Firms
Seventy-five years ago, a young lawyer named Ted Koskoff, figured out a unique way to build a practice: Get other lawyers to give him clients. Today, the statewide firm he founded, Koskoff, Koskoff and Bieder, still gets about 65 to 70 percent of its business from other lawyers... read more

Featured in the Media
  • Damages is a gripping book about a case handled by KK&B's medical malpractice team. | Visit amazon.com for more information
  • Connecticut Top Lawyers
  • Super Lawyers | The Top Attorneys in Connecticut
Damages is a gripping book about a case handled by KK&B's medical malpractice team. It demonstrates KK&B's commitment not only to redress suffering due to medical malpractice but to make sure that doctors and hospitals are more vigilant in the future. Visit amazon.com for more information or to buy it.
Practice Areas How Can I Help You?

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close
Hot Topics

KK&B is currently reviewing claims against:

GlaxoSmith Kline involving the diabetes drug Avandia.

AstraZeneca involving the drug Seroquel. Bayer Healthcare Pharmaceuticals involving the birth control pills Yaz and Yasmine.

If you or a loved one has suffered serious injury as a result of taking Avandia, Seroquel, Yaz or Yasmine, call us at 203-583-8634, or contact us via email.

Carey's Case Review

Court Abuses Discretion in Failing to Poll Jury Regarding Newspaper Article

In Kervick v. Silver Hill Hospital, 128 Conn. App. 341 (2011), the Appellate Court held that... read more